IL6 and Huntington disease: HD + COVID-19 patients showed higher inflammation, measured as higher levels of C-reactive protein and IL-6, and lower lymphocytes and higher aspartate aminotransferase in routine clinical tests on the sampling day compared to uninfected HD patients.